Dr Philip Camilleri

MRCP M.D. FRCR.


Special clinical interest in urology; prostate disease including prostate cancer; testicular; bladder; urological oncology treating with IMRT, IGRT and brachytherapy; chemotherapy including docetaxel and cabazitaxel; hormone therapy including abiraterone (Zytiga) and enzalutamide (Xtandi); bone therapy with Zometa and Denosumab.

LANGUAGES

English

Professional profile

Dr Philip Camilleri was appointed as Consultant Clinical Oncologist in 2006 having trained in clinical oncology in Oxford. He currently specialises in urological cancers – specifically prostate, bladder and testicular cancers – and provides chemotherapy, hormonal as well as radiotherapy treatment.

Dr Camilleri delivers prostate brachytherapy at the Oxford Cancer Centre. He also provides intensity modulated radiotherapy (IMRT) with image guidance (IGRT) for prostate cancers. He is involved in research for most urological cancers.

NHS Hospital
Consultant Clinical Oncologist, Oxford Cancer Centre and Oxford University Hospitals NHS Trust.

Year Qualified
1995

Professional memberships
British Medical Association

Qualifications

    •MD University Of Malta 1995.
    •MRCP Royal College of Physicians (London) 1999.
    •FRCR Royal College of Radiologists (London) 2003.

Research interests
Technical radiotherapy with stereotactic, image guided therapy as well as targeted therapy using advanced imaging techniques.

Clinical interests
Prostate brachytherapy, image-guided radiotherapy (IGRT).

Private secretary
camilleri@privatemedsec.co.uk

Specialities

  • Oncology

Centres